BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//CURE GABA-A - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://curegabaa.org
X-WR-CALDESC:Events for CURE GABA-A
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20240227T120000
DTEND;TZID=America/Los_Angeles:20240227T130000
DTSTAMP:20260419T132339
CREATED:20240127T054440Z
LAST-MODIFIED:20240226T211341Z
UID:2080-1709035200-1709038800@curegabaa.org
SUMMARY:Cure GABA-A | GoF: Discussion on Compounds; Which Ones Work\, Don't & Why?
DESCRIPTION:Dr. Michael Rogawski\, from UC Davis Health\, will explain the Clinical presentation of GABR Variants and current treatments\n\n\nJoin us for an educational session with Dr. Michael Rogawski. \nDr. Michael Rogawski\, a professor and physician at UC Davis Health\, will explain the Clinical presentation of GABR Variants and current treatments. \nHe has been elected a fellow of the National Academy of Inventors (NAI)\, the highest professional distinction for academic inventors. His inventions in drug discovery and development\, particularly in the field of neuropharmacology\, have led to significant advancements in treating epilepsy and neuropsychiatric conditions. \nDr. Rogawski’s election as an NAI fellow recognizes his prolific spirit of innovation and contributions to improving the quality of life through groundbreaking inventions. Notable achievements include the development of epilepsy drug perampanel (Fycompa®) and brexanolone (Zulresso™)\, the first FDA-approved drug for postpartum depression. His work reflects a dedication to translational research and collaboration within the scientific community. \nJoin Cure GABA-A and Dr. Michael Rogawski on Feb 27\, 2024 12:00 PM PST for an educational session. For more details\, contact us on our socials or email: monica@cureGABAa.com. \nCan’t make it in person? Don’t worry – This session will be recorded and uploaded to the Cure GABA-A YouTube channel for your convenience. \n \nJoin us in our collective mission to improve the lives of patients with GABA-A Variants and work toward a brighter future.
URL:https://curegabaa.org/event/cure-gaba-a-webinar-clinical-presentation-of-gabr-variants-and-current/
ATTACH;FMTTYPE=image/jpeg:https://curegabaa.org/wp-content/uploads/2024/01/909be920dac8b8fc6a520c5baeb4ceee-1.jpg
ORGANIZER;CN="CURE GABA-A":MAILTO:info@curegabaa.org
END:VEVENT
END:VCALENDAR